Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00828828
What this trial is testing

Antibody Response to Influenza Vaccine in Patients With Sarcoidosis

Who this might be right for
Pulmonary Sarcoidosis
Shahid Beheshti University of Medical Sciences 49
Large-scale testing (Phase 3)Study completedNCT00803595
What this trial is testing

A Multinational Phase III Study of CS-8958 (MARVEL)

Who this might be right for
Influenza, Human
Daiichi Sankyo Co., Ltd. 1,002
Not applicableActive Not RecruitingNCT05565586
What this trial is testing

Impact of High Dietary Fiber on Microbiome and Vaccine Responses

Who this might be right for
Influenza
M.D. Anderson Cancer Center 31
Large-scale testing (Phase 3)Study completedNCT00505453
What this trial is testing

A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 110
Not applicableNot Yet RecruitingNCT07813481
What this trial is testing

ELderly REspiratory VIral Cohort

Who this might be right for
Influenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2+5 more
Assistance Publique - Hôpitaux de Paris 1,000
Not applicableUnknownNCT05277298
What this trial is testing

Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa

Who this might be right for
SARS-CoV-2 InfectionInfluenzaRespiratory Syncytial Virus (RSV)
National Institute for Communicable Diseases, South Africa 1,200
Testing effectiveness (Phase 2)WithdrawnNCT01045564
What this trial is testing

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
Influenza
GlaxoSmithKline
Not applicableStudy completedNCT04326309
What this trial is testing

Audio Data Collection for Identification and Classification of Coughing

Who this might be right for
COVID-19Coronavirus InfectionsHay Fever+6 more
HealthMode Inc. 336
Testing effectiveness (Phase 2)Study completedNCT00915187
What this trial is testing

Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly

Who this might be right for
Influenza
NasVax Ltd 130
Not applicableStudy completedNCT04288921
What this trial is testing

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Who this might be right for
Influenza, HumanRespiratory Syncytial Virus Infections
LumiraDx UK Limited 525
Testing effectiveness (Phase 2)Study completedNCT00895544
What this trial is testing

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Who this might be right for
InfluenzaAvian Influenza
Alachua Government Services, Inc. 231
Early research (Phase 1)Looking for participantsNCT07110532
What this trial is testing

PH1N1 Blinded Challenge Study

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT04850898
What this trial is testing

Study of SAB-176 in Healthy Adult Participants

Who this might be right for
Influenza A H1N1
SAb Biotherapeutics, Inc. 62
Early research (Phase 1)UnknownNCT02015494
What this trial is testing

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Who this might be right for
Influenza
VaxInnate Corporation 316
Post-approval studies (Phase 4)Study completedNCT00586469
What this trial is testing

Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

Who this might be right for
Influenza Vaccines
GlaxoSmithKline 1,000
Not applicableStudy completedNCT02284594
What this trial is testing

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

Who this might be right for
Influenza
Columbia University 4,026
Post-approval studies (Phase 4)Study completedNCT02908269
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 180
Post-approval studies (Phase 4)Study completedNCT00153556
What this trial is testing

Study to Eliminate Hib Carriage in Rural Alaska Native Villages

Who this might be right for
Haemophilus Influenzae Type BCarrier State
Centers for Disease Control and Prevention 3,200
Testing effectiveness (Phase 2)Study completedNCT00985673
What this trial is testing

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 611
Not applicableStudy completedNCT05674370
What this trial is testing

The GRIP Influenza and SARS-CoV-2 POC Assays

Who this might be right for
COVID-19Influenza
Mayo Clinic 45
Next Page